Press Releases
PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren...
PTC Therapeutics, Inc. today announced that it is expanding the development of ataluren, an investigational new drug, with the initiation of a Phase 2 clinical...
Press Releases
Celator Pharmaceuticals completes enrollment in a second phase 2...
Celator Pharmaceuticals announced that it has completed enrollment in a phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus intensive salvage...
Press Releases
Eurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors...
Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V. announced additional data from a post-hoc analysis of a Phase III clinical trial...
Press Releases
Cephalon Announces FDA Approval of Risk Evaluation and Mitigation...
Cephalon, Inc. (Nasdaq: CEPH) today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL(R) (armodafinil) Tablets and PROVIGIL(R) (modafinil) Tablets ...
Press Releases
FDA approves Herceptin for HER2-positive metastatic stomach cancer
Roche announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil ) for...
Press Releases
Amylin, Lilly and Alkermes Announce Receipt of Complete Response...
Amylin Pharmaceuticals, Inc. Eli Lilly and Company and Alkermes, Inc.announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding...
Press Releases
AVEVA to Exhibit at Drug Delivery Partnerships 2011
Aveva Drug Delivery Systems is pleased to announce that it will exhibit at Drug Delivery Partnerships on 26-28 January 2011 in Miami, Florida,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.